Work

Monitoring blood-based biomarkers as early predictors of progression-free survival in a randomized Bria-ABC phase 3 trial for advanced metastatic breast cancer: An ongoing analysis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2652

Authors: Daniel L. Adams, Chaitali Nangia, Adriana Kahn, Lawrence M. Negret, William Williams, Blaise Bayer, Giuseppe DiPriore, Alexis B. Duffy, Saranya Chumsri

Institutions: Creatv MicroTech (United States), Hoag Memorial Hospital Presbyterian, Yale University, University of Miami, Sylvester Comprehensive Cancer Center, Mayo Clinic in Florida

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162501708

Cites:

Cited by: 1

Related to: